胆阿尔福塞拉酸作为多尼佩西尔联合治疗的比较研究:混合双盲随机对照和开放标签观察试验
Wankiun Lee1, Manho Kim2,3,4
1Department of Neurology, Chungnam National University Hospital, Daejeon, Korea.
Medicine
|June 14, 2024
概括
胆醇酸盐与多内佩西尔相结合,在认知衰退的患者中改善了认知和非认知功能. 这种组合治疗,包括胆醇酸盐 (alpha-glycerylphosphorylcholine),比单独使用多尼佩西尔显著益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆醇酸盐 (alpha-glycerylphosphorylcholine) 是一种含有胆的脂,可以增强乙胆的释放.
- 之前的研究 (ASCOMALVA试验) 表明,将多尼佩西尔与胆醇酸盐结合起来,可以减缓阿尔茨海默病的认知衰退.
研究的目的:
- 为了复制ASCOMALVA试验中观察到的认知益处.
- 为了研究在患有认知衰退的患者中,将多尼佩西尔与其他诺特罗普药物结合使用的疗效,特别是胆醇酸盐,乙-l-卡尼丁和银杏花提取物.
主要方法:
- 119名患有认知能力下降的患者 (MMSE得分≤26) 被随机分为四组:单独使用多尼佩西尔 (DO),多尼佩西尔和胆酸 (DN),多尼佩西尔和乙烯基-l-卡尼丁 (DA),或多尼佩西尔和金科比洛巴提取物 (DG).
- 认知功能在基线,12周和24周被评估,使用迷你精神状态检查 (MMSE),临床痴呆评分,阿尔茨海默病评估尺度-认知子表 (ADAS-Cog) 和阿尔茨海默病评估尺度-非认知子表.
主要成果:
- 在12周后,DN组的MMSE得分增加了3.52%,而DO组的得分增加了1.36%. 在24周,MMSE在DN中增加了1.61%,而在DO中增加了1.07%.
- 在DN组中,ADAS-Cog得分在12周后提高了13.9%,在24周后提高了18.5%,明显高于DO组 (0.9%在12周后,9.4%在24周后).
- 阿尔茨海默病评估尺度-非认知子尺度在12周和24周也显示了DN组的表现优于DO组的表现.
结论:
- 胆酸,当与多尼佩西尔相结合时,在认知和非认知领域提供额外的认知益处.
- 这些发现支持多尼佩西尔和胆醇酸盐组合在管理认知衰退方面的疗效,与ASCOMALVA试验结果一致.
相关概念视频
01:22Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
659
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
659
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
725
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
725
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K